ArticleOncogene2020

Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition.

Aaminah Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.